On Tuesday, April 13, 2021, a man entered a Walgreens store in San Francisco, California, USA.
David Paul Morris | Bloomberg | Getty Images
The Walgreens Boots Alliance on Thursday announced its second-quarter earnings, which is above analysts’ expectations, after boosting demand for booster shots and tests in the Covid-19’s Omicron variant winter months.
The drugstore chain has reiterated its vision for years. It said that consistent earnings per share would increase in less single numbers.
Shares fell about 1% At premarket trading.
Here is what Walgreens reported compared to what analysts had expected in the second quarter ending February 28. Based on refinitiv data:
- Earnings per share: $ 1.59 adjusted vs. 40 1.40 expected
- Revenue: $ 33.76 billion vs. $ 33.4 billion expected
In the quarter, net income fell $ 883 million, or $ 1.02 per share, From বছর 1.03 billion, or $ 1.19 per share, over a year ago.
Excluding items, the company gained $ 1.59 per share, surpassing Expected দ্বারা 1.40 by analysts surveyed by Refinitiv.
Sales fell $ 33.76 billion From $ 32.78 billion a year ago, but exceeded করা 33.4 billion expected by analysts.
As of Wednesday’s close, Walgreens shares have been down 9% so far this year. Shares closed at $ 47.46 on Wednesday, bringing the company’s market value to $ 40.97 billion.
This story is evolving. Please look back for updates.